Portfolio manager Dan LeVan heads Trivalent, a Boston-based international-equity boutique that specializes in non-U.S. developed- and emerging-markets strategies under Victory Capital's umbrella.

This organization has no public members. You must be a member to see who’s a part of this organization.

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16,545.00 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer.

In recent months, the CEO of $205 billion drug giant AstraZeneca (AZN.L), opens new tab has seen his China boss detained by Beijing and his shares underperform rivals. Yet the value which ...

The FDA also granted breakthrough status to AstraZeneca’s Imfinzi for LS-SCLC treatment. Credit: © AstraZeneca 2024. The US Food and Drug Administration (FDA) has ...

Credit: PeopleImages.com – Yuri A/Shutterstock. The Global Coalition for Adaptive Research (GCAR) has executed an agreement to evaluate AstraZeneca‘s AZD1390 compound in the ‘Glioblastoma Adaptive ...

Australian mother-of-one, author, academic and child sexual abuse survivor Professor Gemma Carey has died after a battle with illness.